{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2025,10,27]],"date-time":"2025-10-27T02:26:53Z","timestamp":1761532013031,"version":"build-2065373602"},"reference-count":81,"publisher":"Elsevier BV","issue":"6","license":[{"start":{"date-parts":[[2018,11,1]],"date-time":"2018-11-01T00:00:00Z","timestamp":1541030400000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.elsevier.com\/tdm\/userlicense\/1.0\/"},{"start":{"date-parts":[[2018,11,1]],"date-time":"2018-11-01T00:00:00Z","timestamp":1541030400000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.elsevier.com\/legal\/tdmrep-license"}],"content-domain":{"domain":["brachyjournal.com","clinicalkey.com","clinicalkey.com.au","clinicalkey.es","clinicalkey.fr","clinicalkey.jp","elsevier.com","sciencedirect.com"],"crossmark-restriction":true},"short-container-title":["Brachytherapy"],"published-print":{"date-parts":[[2018,11]]},"DOI":"10.1016\/j.brachy.2018.08.002","type":"journal-article","created":{"date-parts":[[2018,9,2]],"date-time":"2018-09-02T23:42:15Z","timestamp":1535931735000},"page":"912-921","update-policy":"https:\/\/doi.org\/10.1016\/elsevier_cm_policy","source":"Crossref","is-referenced-by-count":8,"title":["Does postoperative irradiation improve survival in early-stage endometrial cancer?"],"prefix":"10.1016","volume":"17","author":[{"given":"Sebastia","family":"Sabater","sequence":"first","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Ignacio","family":"Andres","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Veronica","family":"Lopez-Honrubia","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Maria Magdalena","family":"Marti-Laosa","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Susana","family":"Castro-Larefors","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Roberto","family":"Berenguer","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Esther","family":"Jimenez-Jimenez","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Marimar","family":"Sevillano","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Angeles","family":"Rovirosa","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Meritxell","family":"Arenas","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]}],"member":"78","reference":[{"key":"10.1016\/j.brachy.2018.08.002_bib1","doi-asserted-by":"crossref","first-page":"E359","DOI":"10.1002\/ijc.29210","article-title":"Cancer incidence and mortality worldwide: sources, methods and major patterns in GLOBOCAN 2012","volume":"136","author":"Ferlay","year":"2015","journal-title":"Int J Cancer"},{"key":"10.1016\/j.brachy.2018.08.002_bib2","doi-asserted-by":"crossref","first-page":"1127","DOI":"10.1093\/jnci\/88.16.1127","article-title":"Case-control study of endogenous steroid hormones and endometrial cancer","volume":"88","author":"Potischman","year":"1996","journal-title":"J Natl Cancer Inst"},{"key":"10.1016\/j.brachy.2018.08.002_bib3","doi-asserted-by":"crossref","first-page":"403","DOI":"10.1038\/onc.2012.76","article-title":"Endometrial carcinoma: Molecular alterations involved in tumor development and progression","volume":"32","author":"Yeramian","year":"2012","journal-title":"Oncogene"},{"key":"10.1016\/j.brachy.2018.08.002_bib4","doi-asserted-by":"crossref","first-page":"1568","DOI":"10.1097\/00000478-200412000-00004","article-title":"Serous endometrial cancers that mimic endometrioid adenocarcinomas: A clinicopathologic and immunohistochemical study of a group of problematic cases","volume":"28","author":"Darvishian","year":"2004","journal-title":"Am J Surg Pathol"},{"key":"10.1016\/j.brachy.2018.08.002_bib5","doi-asserted-by":"crossref","first-page":"753","DOI":"10.1097\/PAS.0b013e318247b7bb","article-title":"Molecular profile of grade 3 endometrioid endometrial carcinoma: Is it a type I or type II endometrial carcinoma?","volume":"36","author":"Alvarez","year":"2012","journal-title":"Am J Surg Pathol"},{"key":"10.1016\/j.brachy.2018.08.002_bib6","doi-asserted-by":"crossref","first-page":"15","DOI":"10.1016\/j.ygyno.2011.07.030","article-title":"Should grade 3 endometrioid endometrial carcinoma be considered a type 2 cancer-a clinical and pathological evaluation","volume":"124","author":"Voss","year":"2012","journal-title":"Gynecol Oncol"},{"key":"10.1016\/j.brachy.2018.08.002_bib7","doi-asserted-by":"crossref","first-page":"235","DOI":"10.1097\/GRF.0b013e318218577b","article-title":"The role of lymphadenectomy in endometrial cancer","volume":"54","author":"Kehoe","year":"2011","journal-title":"Clin Obstet Gynecol"},{"key":"10.1016\/j.brachy.2018.08.002_bib8","doi-asserted-by":"crossref","first-page":"2035","DOI":"10.1002\/1097-0142(19901015)60:8+<2035::AID-CNCR2820601515>3.0.CO;2-8","article-title":"Surgical pathologic spread patterns of endometrial cancer. A gynecologic oncology group study","volume":"60","author":"Creasman","year":"1987","journal-title":"Cancer"},{"key":"10.1016\/j.brachy.2018.08.002_bib9","doi-asserted-by":"crossref","first-page":"50","DOI":"10.1016\/j.rpor.2014.09.003","article-title":"The effect of lymphadenectomy and radiotherapy on recurrence and survival in endometrial carcinoma. Experience in a population reference centre","volume":"20","author":"Arenas","year":"2015","journal-title":"Rep Pract Oncol Radiother"},{"key":"10.1016\/j.brachy.2018.08.002_bib10","doi-asserted-by":"crossref","first-page":"29","DOI":"10.1006\/gyno.1995.1005","article-title":"Adenocarcinoma of the endometrium: Survival comparisons of patients with and without pelvic node sampling","volume":"56","author":"Kilgore","year":"1995","journal-title":"Gynecol Oncol"},{"key":"10.1016\/j.brachy.2018.08.002_bib11","doi-asserted-by":"crossref","first-page":"125","DOI":"10.1016\/S0140-6736(08)61766-3","article-title":"Efficacy of systematic pelvic lymphadenectomy in endometrial cancer (MRC ASTEC trial): A randomised study","volume":"373","author":"Kitchener","year":"2009","journal-title":"Lancet"},{"key":"10.1016\/j.brachy.2018.08.002_bib12","doi-asserted-by":"crossref","first-page":"1707","DOI":"10.1093\/jnci\/djn397","article-title":"Systematic pelvic lymphadenectomy vs. no lymphadenectomy in early-stage endometrial carcinoma: randomized clinical trial","volume":"100","author":"Benedetti Panici","year":"2008","journal-title":"J Natl Cancer Inst"},{"key":"10.1016\/j.brachy.2018.08.002_bib13","doi-asserted-by":"crossref","first-page":"389","DOI":"10.1001\/jama.295.4.389","article-title":"Frequency and effect of adjuvant radiation therapy among women with stage I endometrial adenocarcinoma","volume":"295","author":"Lee","year":"2006","journal-title":"JAMA"},{"key":"10.1016\/j.brachy.2018.08.002_bib14","doi-asserted-by":"crossref","first-page":"1872","DOI":"10.1016\/j.ijrobp.2011.03.054","article-title":"The influence of radiation modality and lymph node dissection on survival in early-stage endometrial cancer","volume":"82","author":"Chino","year":"2012","journal-title":"Int J Radiat Oncol Biol Phys"},{"key":"10.1016\/j.brachy.2018.08.002_bib15","doi-asserted-by":"crossref","first-page":"1191","DOI":"10.1097\/IGC.0b013e318229264e","article-title":"Survival of Danish patients with endometrial cancer in the intermediate-risk group not given postoperative radiotherapy: The Danish Endometrial Cancer Study (DEMCA)","volume":"21","author":"Bertelsen","year":"2011","journal-title":"Int J Gynecol Cancer"},{"key":"10.1016\/j.brachy.2018.08.002_bib16","doi-asserted-by":"crossref","first-page":"1237","DOI":"10.1097\/01.AOG.0000292084.34534.c0","article-title":"Adjuvant radiotherapy in incompletely staged IC and II endometrioid uterine cancer","volume":"110","author":"Parthasarathy","year":"2007","journal-title":"Obstet Gynecol"},{"key":"10.1016\/j.brachy.2018.08.002_bib17","doi-asserted-by":"crossref","first-page":"1656","DOI":"10.1093\/jnci\/djt279","article-title":"Cause-specific effects of radiotherapy and lymphadenectomy in stage I-II endometrial cancer: A population-based study","volume":"105","author":"Mell","year":"2013","journal-title":"J Natl Cancer Inst"},{"key":"10.1016\/j.brachy.2018.08.002_bib18","doi-asserted-by":"crossref","first-page":"364","DOI":"10.1097\/COC.0b013e3181b0c266","article-title":"Does brachytherapy improve survival in addition to external beam radiation therapy in patients with high risk stage I and II endometrial carcinoma?","volume":"33","author":"Crosby","year":"2010","journal-title":"Am J Clin Oncol"},{"key":"10.1016\/j.brachy.2018.08.002_bib19","doi-asserted-by":"crossref","first-page":"3724","DOI":"10.1002\/cncr.30228","article-title":"Receipt of vaginal brachytherapy is associated with improved survival in women with stage I endometrioid adenocarcinoma of the uterus: A national cancer data base study","volume":"122","author":"Rydzewski","year":"2016","journal-title":"Cancer"},{"key":"10.1016\/j.brachy.2018.08.002_bib20","doi-asserted-by":"crossref","first-page":"119","DOI":"10.1016\/j.ygyno.2016.10.028","article-title":"Adjuvant radiation therapy is associated with improved overall survival in high-intermediate risk stage I endometrial cancer: A national cancer data base analysis","volume":"144","author":"Gupta","year":"2017","journal-title":"Gynecol Oncol"},{"key":"10.1016\/j.brachy.2018.08.002_bib21","doi-asserted-by":"crossref","first-page":"113","DOI":"10.1016\/j.ygyno.2016.11.003","article-title":"Patterns of adjuvant radiation usage and survival outcomes for stage I endometrial carcinoma in a large hospital-based cohort","volume":"144","author":"Wong","year":"2017","journal-title":"Gynecol Oncol"},{"key":"10.1016\/j.brachy.2018.08.002_bib22","doi-asserted-by":"crossref","first-page":"514","DOI":"10.1016\/j.ygyno.2016.07.091","article-title":"Utilization of adjuvant therapies and their impact on survival for women with stage IIIC endometrial adenocarcinoma","volume":"142","author":"Wong","year":"2016","journal-title":"Gynecol Oncol"},{"key":"10.1016\/j.brachy.2018.08.002_bib23","doi-asserted-by":"crossref","first-page":"452","DOI":"10.1016\/j.radonc.2016.12.003","article-title":"Improved overall survival with adjuvant radiotherapy for high-intermediate and high risk stage I endometrial cancer","volume":"122","author":"Harkenrider","year":"2017","journal-title":"Radiother Oncol"},{"key":"10.1016\/j.brachy.2018.08.002_bib24","doi-asserted-by":"crossref","first-page":"1115","DOI":"10.1002\/(SICI)1097-0142(19960315)77:6<1115::AID-CNCR17>3.0.CO;2-4","article-title":"Pathologic models to predict outcome for women with endometrial adenocarcinoma: The importance of the distinction between surgical stage and clinical stage\u2013a gynecologic oncology group study","volume":"77","author":"Zaino","year":"1996","journal-title":"Cancer"},{"key":"10.1016\/j.brachy.2018.08.002_bib25","doi-asserted-by":"crossref","first-page":"31","DOI":"10.1002\/ssu.2980100107","article-title":"FIGO stage, histology, histologic grade, age and race as prognostic factors in determining survival for cancers of the female gynecological system: An analysis of 1973-87 SEER cases of cancers of the endometrium, cervix, ovary, vulva, and vagina","volume":"10","author":"Kosary","year":"1994","journal-title":"Semin Surg Oncol"},{"key":"10.1016\/j.brachy.2018.08.002_bib26","doi-asserted-by":"crossref","first-page":"197","DOI":"10.1136\/ijgc-00009577-200303000-00017","article-title":"Multivariate independent prognostic factors in endometrial carcinoma: A clinicopathologic study in 181 patients: 10 years experience at the department of obstetrics and gynecology of the Mainz University","volume":"13","author":"Steiner","year":"2003","journal-title":"Int J Gynecol Cancer"},{"key":"10.1016\/j.brachy.2018.08.002_bib27","doi-asserted-by":"crossref","first-page":"142","DOI":"10.1016\/0090-8258(92)90276-O","article-title":"The prognostic significance of surgical staging for carcinoma of the endometrium","volume":"45","author":"Wolfson","year":"1992","journal-title":"Gynecol Oncol"},{"key":"10.1016\/j.brachy.2018.08.002_bib28","doi-asserted-by":"crossref","first-page":"491","DOI":"10.1016\/S0140-6736(05)67063-8","article-title":"Endometrial cancer","volume":"366","author":"Amant","year":"2005","journal-title":"Lancet"},{"key":"10.1016\/j.brachy.2018.08.002_bib29","doi-asserted-by":"crossref","first-page":"245","DOI":"10.1038\/sj.bjc.6600698","article-title":"Prognostic significance of positive peritoneal cytology in endometrial carcinoma confined to the uterus","volume":"88","author":"Kasamatsu","year":"2003","journal-title":"Br J Cancer"},{"key":"10.1016\/j.brachy.2018.08.002_bib30","doi-asserted-by":"crossref","first-page":"470","DOI":"10.1006\/gyno.2001.6301","article-title":"Positive peritoneal cytology in endometrial cancer: Enhancement of other prognostic indicators","volume":"82","author":"Takeshima","year":"2001","journal-title":"Gynecol Oncol"},{"key":"10.1016\/j.brachy.2018.08.002_bib31","doi-asserted-by":"crossref","first-page":"38","DOI":"10.1006\/gyno.2002.6713","article-title":"Assessment of prognostic factors in stage IIIA endometrial cancer","volume":"86","author":"Mariani","year":"2002","journal-title":"Gynecol Oncol"},{"key":"10.1016\/j.brachy.2018.08.002_bib32","doi-asserted-by":"crossref","first-page":"77","DOI":"10.1016\/j.ygyno.2012.09.026","article-title":"Positive peritoneal cytology is an independent risk-factor in early stage endometrial cancer","volume":"128","author":"Garg","year":"2013","journal-title":"Gynecol Oncol"},{"key":"10.1016\/j.brachy.2018.08.002_bib33","first-page":"3097","article-title":"Peritoneal cytology and preoperative serum CA 125 level are important prognostic indicators of overall survival in advanced endometrial cancer","volume":"23","author":"Santala","year":"2003","journal-title":"Anticancer Res"},{"key":"10.1016\/j.brachy.2018.08.002_bib34","doi-asserted-by":"crossref","first-page":"9","DOI":"10.1046\/j.1525-1438.1992.02010009.x","article-title":"Carcinoma of the endometrium in Norway: A histopathological and prognostic survey of a total population","volume":"2","author":"Abeler","year":"1992","journal-title":"Int J Gynecol Cancer"},{"key":"10.1016\/j.brachy.2018.08.002_bib35","doi-asserted-by":"crossref","first-page":"274","DOI":"10.1006\/gyno.2002.6836","article-title":"Surgical stage I endometrial cancer: Predictors of distant failure and death","volume":"87","author":"Mariani","year":"2002","journal-title":"Gynecol Oncol"},{"key":"10.1016\/j.brachy.2018.08.002_bib36","series-title":"Uterine cancer. Screening, diagnosis and treatment","first-page":"105","article-title":"Prognostic factors in uterine cancer","author":"Baker","year":"2009"},{"key":"10.1016\/j.brachy.2018.08.002_bib37","doi-asserted-by":"crossref","first-page":"e631","DOI":"10.1016\/j.ijrobp.2011.04.013","article-title":"Fifteen-year radiotherapy outcomes of the randomized PORTEC-1 trial for endometrial carcinoma","volume":"81","author":"Creutzberg","year":"2011","journal-title":"Int J Radiat Oncol Biol Phys"},{"key":"10.1016\/j.brachy.2018.08.002_bib38","doi-asserted-by":"crossref","first-page":"912","DOI":"10.1309\/CP3HGX7H753QQU8T","article-title":"Lymphovascular invasion is a significant predictor for distant recurrence in patients with early-stage endometrial endometrioid adenocarcinoma","volume":"129","author":"Nofech-Mozes","year":"2008","journal-title":"Am J Clin Pathol"},{"key":"10.1016\/j.brachy.2018.08.002_bib39","doi-asserted-by":"crossref","first-page":"799","DOI":"10.1016\/j.ygyno.2004.11.033","article-title":"Lymphvascular space involvement: An independent prognostic factor in endometrial cancer","volume":"96","author":"Briet","year":"2005","journal-title":"Gynecol Oncol"},{"key":"10.1016\/j.brachy.2018.08.002_bib40","doi-asserted-by":"crossref","first-page":"1777","DOI":"10.1002\/1097-0142(20010501)91:9<1777::AID-CNCR1196>3.0.CO;2-#","article-title":"Significance of perivascular lymphocytic infiltrates in endometrial carcinoma","volume":"91","author":"Yamazawa","year":"2001","journal-title":"Cancer"},{"key":"10.1016\/j.brachy.2018.08.002_bib41","doi-asserted-by":"crossref","first-page":"243","DOI":"10.1006\/gyno.2002.6825","article-title":"Should the presence of lymphvascular space involvement be used to assign patients to adjuvant therapy following hysterectomy for unstaged endometrial cancer?","volume":"87","author":"Cohn","year":"2002","journal-title":"Gynecol Oncol"},{"key":"10.1016\/j.brachy.2018.08.002_bib42","doi-asserted-by":"crossref","first-page":"1404","DOI":"10.1016\/S0140-6736(00)02139-5","article-title":"Surgery and postoperative radiotherapy versus surgery alone for patients with stage-1 endometrial carcinoma: multicentre randomised trial. PORTEC Study Group. Post operative radiation therapy in endometrial carcinoma","volume":"355","author":"Creutzberg","year":"2000","journal-title":"Lancet"},{"key":"10.1016\/j.brachy.2018.08.002_bib43","doi-asserted-by":"crossref","first-page":"816","DOI":"10.1016\/S0140-6736(09)62163-2","article-title":"Vaginal brachytherapy versus pelvic external beam radiotherapy for patients with endometrial cancer of high-intermediate risk (PORTEC-2): An open-label, non-inferiority, randomised trial","volume":"375","author":"Nout","year":"2010","journal-title":"Lancet"},{"key":"10.1016\/j.brachy.2018.08.002_bib44","doi-asserted-by":"crossref","first-page":"744","DOI":"10.1016\/j.ygyno.2003.11.048","article-title":"A phase III trial of surgery with or without adjunctive external pelvic radiation therapy in intermediate risk endometrial adenocarcinoma: A Gynecologic Oncology Group study","volume":"92","author":"Keys","year":"2004","journal-title":"Gynecol Oncol"},{"issue":"Suppl 6","key":"10.1016\/j.brachy.2018.08.002_bib45","doi-asserted-by":"crossref","first-page":"vi33","DOI":"10.1093\/annonc\/mdt353","article-title":"Endometrial cancer: ESMO clinical practice guidelines for diagnosis, treatment and follow-up","volume":"24","author":"Colombo","year":"2013","journal-title":"Ann Oncol"},{"key":"10.1016\/j.brachy.2018.08.002_bib46","doi-asserted-by":"crossref","first-page":"2","DOI":"10.1097\/IGC.0000000000000609","article-title":"ESMO-ESGO-ESTRO consensus conference on endometrial cancer: diagnosis, treatment and follow-up","volume":"26","author":"Colombo","year":"2016","journal-title":"Int J Gynecol Cancer"},{"key":"10.1016\/j.brachy.2018.08.002_bib47","doi-asserted-by":"crossref","first-page":"137","DOI":"10.1016\/S0140-6736(08)61767-5","article-title":"Adjuvant external beam radiotherapy in the treatment of endometrial cancer (MRC ASTEC and NCIC CTG EN.5 randomised trials): pooled trial results, systematic review, and meta-analysis","volume":"373","author":"Blake","year":"2009","journal-title":"Lancet"},{"key":"10.1016\/j.brachy.2018.08.002_bib48","doi-asserted-by":"crossref","first-page":"2908","DOI":"10.1200\/JCO.2015.62.5459","article-title":"Postoperative radiation therapy for endometrial cancer: American society of clinical oncology clinical practice guideline endorsement of the American society for radiation oncology evidence-based guideline","volume":"33","author":"Meyer","year":"2015","journal-title":"J Clin Oncol"},{"key":"10.1016\/j.brachy.2018.08.002_bib49","doi-asserted-by":"crossref","first-page":"562 e561","DOI":"10.1016\/j.ajog.2011.09.001","article-title":"Lymphadenectomy influences the utilization of adjuvant radiation treatment for endometrial cancer","volume":"205","author":"Sharma","year":"2011","journal-title":"Am J Obstet Gynecol"},{"key":"10.1016\/j.brachy.2018.08.002_bib50","first-page":"419","article-title":"Postoperative external irradiation and prognostic parameters in stage I endometrial carcinoma: clinical and histopathologic study of 540 patients","volume":"56","author":"Aalders","year":"1980","journal-title":"Obstet Gynecol"},{"key":"10.1016\/j.brachy.2018.08.002_bib51","doi-asserted-by":"crossref","first-page":"873","DOI":"10.1111\/IGC.0b013e3181a6c9df","article-title":"Intravaginal brachytherapy in FIGO stage I low-risk endometrial cancer: a controlled randomized study","volume":"19","author":"Sorbe","year":"2009","journal-title":"Int J Gynecol Cancer"},{"key":"10.1016\/j.brachy.2018.08.002_bib52","doi-asserted-by":"crossref","first-page":"1249","DOI":"10.1016\/j.ijrobp.2011.04.014","article-title":"External pelvic and vaginal irradiation versus vaginal irradiation alone as postoperative therapy in medium-risk endometrial carcinoma--a prospective randomized study","volume":"82","author":"Sorbe","year":"2012","journal-title":"Int J Radiat Oncol Biol Phys"},{"key":"10.1016\/j.brachy.2018.08.002_bib53","doi-asserted-by":"crossref","first-page":"194","DOI":"10.1006\/gyno.2001.6494","article-title":"Conservative management of stage I endometrial carcinoma after surgical staging","volume":"84","author":"Straughn","year":"2002","journal-title":"Gynecol Oncol"},{"key":"10.1016\/j.brachy.2018.08.002_bib54","doi-asserted-by":"crossref","first-page":"302","DOI":"10.1097\/COC.0000000000000273","article-title":"Stage I and II endometrial adenocarcinoma: Analysis of 2009 FIGO staging revision and impact on survival by adjuvant therapy","volume":"41","author":"Cahan","year":"2018","journal-title":"Am J Clin Oncol"},{"key":"10.1016\/j.brachy.2018.08.002_bib55","doi-asserted-by":"crossref","first-page":"384","DOI":"10.1016\/S1470-2045(17)30068-2","article-title":"A comparison of sentinel lymph node biopsy to lymphadenectomy for endometrial cancer staging (FIRES trial): A multicentre, prospective, cohort study","volume":"18","author":"Rossi","year":"2017","journal-title":"Lancet Oncol"},{"key":"10.1016\/j.brachy.2018.08.002_bib56","doi-asserted-by":"crossref","first-page":"434","DOI":"10.1016\/j.ygyno.2016.04.010","article-title":"The role of adjuvant radiation in lymph node positive endometrial adenocarcinoma","volume":"141","author":"Shaikh","year":"2016","journal-title":"Gynecol Oncol"},{"key":"10.1016\/j.brachy.2018.08.002_bib57","doi-asserted-by":"crossref","first-page":"1040","DOI":"10.1016\/j.ijrobp.2016.12.035","article-title":"Brachytherapy improves survival in stage III endometrial cancer with cervical involvement","volume":"97","author":"Bingham","year":"2017","journal-title":"Int J Radiat Oncol Biol Phys"},{"key":"10.1016\/j.brachy.2018.08.002_bib58","doi-asserted-by":"crossref","first-page":"335","DOI":"10.1097\/COC.0000000000000065","article-title":"Adjuvant pelvic radiation therapy+\/-vaginal brachytherapy in patients with high-risk stage I or stage II uterine papillary serous, clear cell, and high-grade endometrioid carcinoma","volume":"39","author":"Nagar","year":"2016","journal-title":"Am J Clin Oncol"},{"key":"10.1016\/j.brachy.2018.08.002_bib59","doi-asserted-by":"crossref","first-page":"85","DOI":"10.1097\/IGC.0000000000000844","article-title":"Survival differences among uterine papillary serous, clear cell and grade 3 endometrioid adenocarcinoma endometrial cancers: A national cancer database analysis","volume":"27","author":"McGunigal","year":"2017","journal-title":"Int J Gynecol Cancer"},{"key":"10.1016\/j.brachy.2018.08.002_bib60","doi-asserted-by":"crossref","first-page":"147","DOI":"10.1016\/j.ygyno.2017.11.010","article-title":"Adjuvant therapy in patients with clear cell endometrial carcinoma: An analysis of the national cancer database","volume":"148","author":"Nieto","year":"2018","journal-title":"Gynecol Oncol"},{"key":"10.1016\/j.brachy.2018.08.002_bib61","doi-asserted-by":"crossref","first-page":"145","DOI":"10.1016\/j.ygyno.2006.07.009","article-title":"Interfractional variation of uterine position during radical RT: Weekly CT evaluation","volume":"104","author":"Lee","year":"2007","journal-title":"Gynecol Oncol"},{"key":"10.1016\/j.brachy.2018.08.002_bib62","doi-asserted-by":"crossref","first-page":"1625","DOI":"10.1093\/jnci\/djs374","article-title":"Adjuvant radiotherapy for stage i endometrial cancer: An updated cochrane systematic review and meta-analysis","volume":"104","author":"Kong","year":"2012","journal-title":"J Natl Cancer Inst"},{"key":"10.1016\/j.brachy.2018.08.002_bib63","doi-asserted-by":"crossref","first-page":"1595","DOI":"10.1093\/annonc\/mdm066","article-title":"Adjuvant radiotherapy for stage I endometrial cancer: Systematic review and meta-analysis","volume":"18","author":"Kong","year":"2007","journal-title":"Ann Oncol"},{"key":"10.1016\/j.brachy.2018.08.002_bib64","doi-asserted-by":"crossref","first-page":"307","DOI":"10.1097\/IGC.0000000000000615","article-title":"Salvage versus adjuvant radiation treatment for women with early-stage endometrial carcinoma: A matched analysis","volume":"26","author":"Vance","year":"2016","journal-title":"Int J Gynecol Cancer"},{"key":"10.1016\/j.brachy.2018.08.002_bib65","first-page":"1977","article-title":"An intensive follow-up does not change survival of patients with clinical stage I endometrial cancer","volume":"20","author":"Gadducci","year":"2000","journal-title":"Anticancer Res"},{"key":"10.1016\/j.brachy.2018.08.002_bib66","doi-asserted-by":"crossref","first-page":"1800","DOI":"10.3892\/ol.2014.2362","article-title":"Natural history of recurrences in endometrial carcinoma","volume":"8","author":"Sorbe","year":"2014","journal-title":"Oncol Lett"},{"key":"10.1016\/j.brachy.2018.08.002_bib67","first-page":"4347","article-title":"Disease-free interval after primary treatment predicts prognosis of recurrent endometrial carcinoma","volume":"30","author":"Ueda","year":"2010","journal-title":"Anticancer Res"},{"key":"10.1016\/j.brachy.2018.08.002_bib68","doi-asserted-by":"crossref","first-page":"1366","DOI":"10.1016\/S0360-3016(03)00414-0","article-title":"Definitive radiotherapy for patients with isolated vaginal recurrence of endometrial carcinoma after hysterectomy","volume":"56","author":"Jhingran","year":"2003","journal-title":"Int J Radiat Oncol Biol Phys"},{"key":"10.1016\/j.brachy.2018.08.002_bib69","doi-asserted-by":"crossref","first-page":"500","DOI":"10.1016\/j.ijrobp.2005.02.004","article-title":"Definitive radiotherapy in the management of isolated vaginal recurrences of endometrial cancer","volume":"63","author":"Lin","year":"2005","journal-title":"Int J Radiat Oncol Biol Phys"},{"key":"10.1016\/j.brachy.2018.08.002_bib70","doi-asserted-by":"crossref","first-page":"36","DOI":"10.1200\/JCO.2004.00.7617","article-title":"Randomized phase III trial of whole-abdominal irradiation versus doxorubicin and cisplatin chemotherapy in advanced endometrial carcinoma: A gynecologic oncology group study","volume":"24","author":"Randall","year":"2006","journal-title":"J Clin Oncol"},{"key":"10.1016\/j.brachy.2018.08.002_bib71","doi-asserted-by":"crossref","first-page":"333","DOI":"10.1002\/cncr.26295","article-title":"Underascertainment of radiotherapy receipt in surveillance, epidemiology, and end results registry data","volume":"118","author":"Jagsi","year":"2012","journal-title":"Cancer"},{"key":"10.1016\/j.brachy.2018.08.002_bib72","doi-asserted-by":"crossref","first-page":"260","DOI":"10.1186\/s13014-014-0260-0","article-title":"Quality assurance in radiotherapy: Analysis of the causes of not starting or early radiotherapy withdrawal","volume":"9","author":"Arenas","year":"2014","journal-title":"Radiat Oncol"},{"key":"10.1016\/j.brachy.2018.08.002_bib73","first-page":"351","article-title":"Vaginal cuff brachytherapy in endometrial cancer\u2013a technically easy treatment?","volume":"9","author":"Sabater","year":"2017","journal-title":"Canc Manag Res"},{"key":"10.1016\/j.brachy.2018.08.002_bib74","doi-asserted-by":"crossref","first-page":"179","DOI":"10.1016\/j.radonc.2016.02.032","article-title":"Analysing the integration of MR images acquired in a non-radiotherapy treatment position into the radiotherapy workflow using deformable and rigid registration","volume":"119","author":"Sabater","year":"2016","journal-title":"Radiother Oncol"},{"key":"10.1016\/j.brachy.2018.08.002_bib75","doi-asserted-by":"crossref","first-page":"248","DOI":"10.1007\/s00066-016-0940-9","article-title":"Effect of rectal enemas on rectal dosimetric parameters during high-dose-rate vaginal cuff brachytherapy: A prospective trial","volume":"192","author":"Sabater","year":"2016","journal-title":"Strahlenther Onkol"},{"key":"10.1016\/j.brachy.2018.08.002_bib76","doi-asserted-by":"crossref","first-page":"35","DOI":"10.1016\/j.brachy.2015.10.005","article-title":"Rectal contrast increases rectal dose during vaginal cuff brachytherapy","volume":"15","author":"Sabater","year":"2016","journal-title":"Brachytherapy"},{"key":"10.1016\/j.brachy.2018.08.002_bib77","doi-asserted-by":"crossref","first-page":"925","DOI":"10.1007\/s12094-015-1463-z","article-title":"Vaginal-cuff control and toxicity results of a daily HDR brachytherapy schedule in endometrial cancer patients","volume":"18","author":"Rios","year":"2016","journal-title":"Clin Transl Oncol"},{"key":"10.1016\/j.brachy.2018.08.002_bib78","doi-asserted-by":"crossref","first-page":"147","DOI":"10.1016\/j.brachy.2016.10.001","article-title":"A new short daily brachytherapy schedule in postoperative endometrial carcinoma. Preliminary results","volume":"16","author":"Rovirosa","year":"2017","journal-title":"Brachytherapy"},{"key":"10.1016\/j.brachy.2018.08.002_bib79","doi-asserted-by":"crossref","first-page":"1169","DOI":"10.1016\/j.brachy.2017.07.003","article-title":"Comparative results of three short brachytherapy schedules as exclusive treatment in postoperative endometrial carcinoma","volume":"16","author":"Rovirosa","year":"2017","journal-title":"Brachytherapy"},{"key":"10.1016\/j.brachy.2018.08.002_bib80","doi-asserted-by":"crossref","first-page":"473","DOI":"10.4143\/crt.2014.115","article-title":"Body mass index and doses at organs at risk in a Mediterranean population treated with postoperative vaginal cuff brachytherapy","volume":"47","author":"Sabater","year":"2015","journal-title":"Canc Res Treat"},{"key":"10.1016\/j.brachy.2018.08.002_bib81","doi-asserted-by":"crossref","DOI":"10.1007\/s12094-018-1872-x","article-title":"Are endometrial cancer radiotherapy results age related?","author":"Rovirosa","year":"2018","journal-title":"Clin Transl Oncol"}],"container-title":["Brachytherapy"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S1538472118300631?httpAccept=text\/xml","content-type":"text\/xml","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S1538472118300631?httpAccept=text\/plain","content-type":"text\/plain","content-version":"vor","intended-application":"text-mining"}],"deposited":{"date-parts":[[2025,10,27]],"date-time":"2025-10-27T02:14:47Z","timestamp":1761531287000},"score":1,"resource":{"primary":{"URL":"https:\/\/linkinghub.elsevier.com\/retrieve\/pii\/S1538472118300631"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2018,11]]},"references-count":81,"journal-issue":{"issue":"6","published-print":{"date-parts":[[2018,11]]}},"alternative-id":["S1538472118300631"],"URL":"https:\/\/doi.org\/10.1016\/j.brachy.2018.08.002","relation":{},"ISSN":["1538-4721"],"issn-type":[{"type":"print","value":"1538-4721"}],"subject":[],"published":{"date-parts":[[2018,11]]},"assertion":[{"value":"Elsevier","name":"publisher","label":"This article is maintained by"},{"value":"Does postoperative irradiation improve survival in early-stage endometrial cancer?","name":"articletitle","label":"Article Title"},{"value":"Brachytherapy","name":"journaltitle","label":"Journal Title"},{"value":"https:\/\/doi.org\/10.1016\/j.brachy.2018.08.002","name":"articlelink","label":"CrossRef DOI link to publisher maintained version"},{"value":"article","name":"content_type","label":"Content Type"},{"value":"\u00a9 2018 American Brachytherapy Society. Published by Elsevier Inc. All rights reserved.","name":"copyright","label":"Copyright"}]}}